首页 > 最新文献

Infectious Medicine最新文献

英文 中文
Bacille-Calmette-Guerin modulates human macrophage and dendritic cell response to SARS-CoV-2 S-glycoprotein Bacille Calmette Guerin调节人类巨噬细胞和树突状细胞对严重急性呼吸系统综合征冠状病毒2型S糖蛋白的反应
Pub Date : 2023-09-01 DOI: 10.1016/j.imj.2023.08.004
Regina C. Ambe , Shubhang Bhalla , Alejandra Alvarado , Jose Barragan , Jorge Cervantes

Background

Given that epidemiological evidence suggests a potential protective role for Bacille-Calmette-Guerin against COVID-19, we aimed to explore whether pre-exposure of human monocyte-derived macrophages and dendritic cells to BCG could modulate their response to SARS-CoV-2 S-glycoprotein.

Methods

Dual THP-1 cells containing 2 reporter plasmids for transcription factors NF-κB, and IRF were differentiated into macrophages over 3 days using phorbol 12-myristate 13-acetate, or into dendritic cells over 6 days using commercial monocyte-dencritic cell differentiation media and matured with recombinant tumor necrosis factor-α. Cells were exposed to BCG for 24 h and then stimulated with SARS-CoV-2 S-glycoprotein for 24 hours.

Results

Pre-exposure of human macrophages and DCs to BCG increased IRF and NF-kb activation in response to the SARS-CoV-2 S-glycoprotein.

Conclusions

Our results showed that pre-exposure of both types of cells to BCG exhibited an increase in inflammatory transcription factors upon stimulation with S-glycoprotein. BCG-induced trained immunity may be an important tool for reducing susceptibility to SARS-CoV-2 infection and severity of COVID-19. Our findings help in the design of future BCG-based therapeutic approaches in the treatment of diseases caused by viral infections.

背景鉴于流行病学证据表明Bacille-Calmette-Guerin对新冠肺炎具有潜在的保护作用,我们旨在探索人类单核细胞衍生的巨噬细胞和树突状细胞预先暴露于BCG是否可以调节其对SARS-CoV-2 S糖蛋白的反应,和IRF在3天内使用佛波醇12-肉豆蔻酸盐13-乙酸盐分化为巨噬细胞,或在6天内使用商业单核细胞dencritic细胞分化培养基分化为树突状细胞,并用重组肿瘤坏死因子-α成熟。将细胞暴露于BCG 24小时,然后用SARS-CoV-2 S-糖蛋白刺激24小时。结果人巨噬细胞和树突状细胞预暴露于BCG增加了对严重急性呼吸系统综合征冠状病毒2型S糖蛋白的IRF和NF-kb激活。结论我们的结果表明,两种类型的细胞预暴露在BCG刺激下,炎症转录因子均增加。BCG诱导的训练免疫可能是降低对SARS-CoV-2感染的易感性和新冠肺炎严重程度的重要工具。我们的发现有助于设计未来基于BCG的治疗方法,以治疗病毒感染引起的疾病。
{"title":"Bacille-Calmette-Guerin modulates human macrophage and dendritic cell response to SARS-CoV-2 S-glycoprotein","authors":"Regina C. Ambe ,&nbsp;Shubhang Bhalla ,&nbsp;Alejandra Alvarado ,&nbsp;Jose Barragan ,&nbsp;Jorge Cervantes","doi":"10.1016/j.imj.2023.08.004","DOIUrl":"https://doi.org/10.1016/j.imj.2023.08.004","url":null,"abstract":"<div><h3>Background</h3><p>Given that epidemiological evidence suggests a potential protective role for Bacille-Calmette-Guerin against COVID-19, we aimed to explore whether pre-exposure of human monocyte-derived macrophages and dendritic cells to BCG could modulate their response to SARS-CoV-2 S-glycoprotein.</p></div><div><h3>Methods</h3><p>Dual THP-1 cells containing 2 reporter plasmids for transcription factors NF-κB, and IRF were differentiated into macrophages over 3 days using phorbol 12-myristate 13-acetate, or into dendritic cells over 6 days using commercial monocyte-dencritic cell differentiation media and matured with recombinant tumor necrosis factor-α. Cells were exposed to BCG for 24 h and then stimulated with SARS-CoV-2 S-glycoprotein for 24 hours.</p></div><div><h3>Results</h3><p>Pre-exposure of human macrophages and DCs to BCG increased IRF and NF-kb activation in response to the SARS-CoV-2 S-glycoprotein.</p></div><div><h3>Conclusions</h3><p>Our results showed that pre-exposure of both types of cells to BCG exhibited an increase in inflammatory transcription factors upon stimulation with S-glycoprotein. BCG-induced trained immunity may be an important tool for reducing susceptibility to SARS-CoV-2 infection and severity of COVID-19. Our findings help in the design of future BCG-based therapeutic approaches in the treatment of diseases caused by viral infections.</p></div>","PeriodicalId":100667,"journal":{"name":"Infectious Medicine","volume":"2 3","pages":"Pages 241-245"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50183467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes 严重急性呼吸系统综合征冠状病毒2型感染在促进异常免疫反应和败血症中的作用:严重急性呼吸系综合征冠状病毒-2型相关败血症和其他原因败血症的比较
Pub Date : 2023-09-01 DOI: 10.1016/j.imj.2023.04.006
Andrea Piccioni , Laura Franza , Federico Rosa , Marcello Candelli , Marcello Covino , Michela Ferrara , Gianpietro Volonnino , Giuseppe Bertozzi , Maria Vittoria Zamponi , Aniello Maiese , Gabriele Savioli , Francesco Franceschi , Raffaele La Russa

Background

COVID-19 caused by SARS-CoV-2 virus is characterized by respiratory compromise and immune system involvement, even leading to serious disorders, such as cytokine storm.

Methods

We then conducted a literature review on the topic of sepsis and covid-19, and in parallel conducted an experimental study on the histological finding of patients who died from SARS-Covid 19 infection and a control group.

Results

Sepsis associated with covid-19 infection has some similarities and differences from that from other causes.

Conclusion

In this paper the complex interplay between the 2 disorders was discussed, focusing on the similarities and on the effect that one could have on the other. A preliminary experimental section that demonstrates the multisystemic involvement in subjects who die from SARS-CoV-2 is also proposed.

背景由严重急性呼吸系统综合征冠状病毒2型引起的新冠肺炎以呼吸系统损害和免疫系统受累为特征,甚至会导致严重的疾病,如细胞因子风暴。方法对脓毒症和新冠肺炎进行文献回顾,同时对死于SARS-covid 19感染的患者和对照组的组织学发现进行实验研究。结果新冠肺炎感染脓毒症与其他病因有一定的异同。结论本文讨论了这两种疾病之间复杂的相互作用,重点讨论了它们的相似性以及其中一种可能对另一种产生的影响。还提出了一个初步实验部分,证明死于严重急性呼吸系统综合征冠状病毒2型的受试者的多系统参与。
{"title":"The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes","authors":"Andrea Piccioni ,&nbsp;Laura Franza ,&nbsp;Federico Rosa ,&nbsp;Marcello Candelli ,&nbsp;Marcello Covino ,&nbsp;Michela Ferrara ,&nbsp;Gianpietro Volonnino ,&nbsp;Giuseppe Bertozzi ,&nbsp;Maria Vittoria Zamponi ,&nbsp;Aniello Maiese ,&nbsp;Gabriele Savioli ,&nbsp;Francesco Franceschi ,&nbsp;Raffaele La Russa","doi":"10.1016/j.imj.2023.04.006","DOIUrl":"https://doi.org/10.1016/j.imj.2023.04.006","url":null,"abstract":"<div><h3>Background</h3><p>COVID-19 caused by SARS-CoV-2 virus is characterized by respiratory compromise and immune system involvement, even leading to serious disorders, such as cytokine storm.</p></div><div><h3>Methods</h3><p>We then conducted a literature review on the topic of sepsis and covid-19, and in parallel conducted an experimental study on the histological finding of patients who died from SARS-Covid 19 infection and a control group.</p></div><div><h3>Results</h3><p>Sepsis associated with covid-19 infection has some similarities and differences from that from other causes.</p></div><div><h3>Conclusion</h3><p>In this paper the complex interplay between the 2 disorders was discussed, focusing on the similarities and on the effect that one could have on the other. A preliminary experimental section that demonstrates the multisystemic involvement in subjects who die from SARS-CoV-2 is also proposed.</p></div>","PeriodicalId":100667,"journal":{"name":"Infectious Medicine","volume":"2 3","pages":"Pages 202-211"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50183420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A new method for accurate calculation of case fatality rates during a pandemic: Mathematical deduction based on population-level big data 准确计算疫情期间病死率的新方法:基于人口水平大数据的数学推导
Pub Date : 2023-06-01 DOI: 10.1016/j.imj.2023.03.002
Jinqi Feng, Hui Luo, Yi Wu, Qian Zhou, Rui Qi

Background

During the course of an epidemic of a potentially fatal disease, it is difficult to accurately estimate the case fatality rate (CFR) because many calculation methods do not account for the delay between case confirmation and disease outcome. Taking the coronavirus disease-2019 (COVID-19) as an example, this study aimed to develop a new method for CFR calculation while the pandemic was ongoing.

Methods

We developed a new method for CFR calculation based on the following formula: number of deaths divided by the number of cases T days before, where T is the average delay between case confirmation and disease outcome. An objective law was found using simulated data that states if the hypothesized T is equal to the true T, the calculated real-time CFR remains constant; whereas if the hypothesized T is greater (or smaller) than the true T, the real-time CFR will gradually decrease (or increase) as the days progress until it approaches the true CFR.

Results

Based on the discovered law, it was estimated that the true CFR of COVID-19 at the initial stage of the pandemic in China, excluding Hubei Province, was 0.8%; and in Hubei Province, it was 6.6%. The calculated CFRs predicted the death count with almost complete accuracy.

Conclusions

The method could be used for the accurate calculation of the true CFR during a pandemic, instead of waiting until the end of the pandemic, whether the pandemic is under control or not. It could provide those involved in outbreak control a clear view of the timeliness of case confirmations.

背景在一种潜在致命疾病的流行过程中,由于许多计算方法没有考虑到病例确认和疾病结果之间的延迟,因此很难准确估计病死率。以2019冠状病毒病(新冠肺炎)为例,本研究旨在开发一种在大流行期间计算病死率的新方法。方法我们根据以下公式开发了一种新的CFR计算方法:死亡人数除以T天前的病例数,其中T是病例确认和疾病结果之间的平均延迟。使用模拟数据发现了一个客观定律,即如果假设的T等于真实的T,则计算的实时CFR保持不变;而如果假设T大于(或小于)真实T,则实时病死率将随着天数的推移逐渐降低(或增加),直到接近真实病死率;湖北省为6.6%。计算的CFRs几乎完全准确地预测了死亡人数。结论无论疫情是否得到控制,该方法都可以用于准确计算疫情期间的真实病死率,而不是等到疫情结束。它可以让那些参与疫情控制的人清楚地了解病例确认的及时性。
{"title":"A new method for accurate calculation of case fatality rates during a pandemic: Mathematical deduction based on population-level big data","authors":"Jinqi Feng,&nbsp;Hui Luo,&nbsp;Yi Wu,&nbsp;Qian Zhou,&nbsp;Rui Qi","doi":"10.1016/j.imj.2023.03.002","DOIUrl":"https://doi.org/10.1016/j.imj.2023.03.002","url":null,"abstract":"<div><h3>Background</h3><p>During the course of an epidemic of a potentially fatal disease, it is difficult to accurately estimate the case fatality rate (CFR) because many calculation methods do not account for the delay between case confirmation and disease outcome. Taking the coronavirus disease-2019 (COVID-19) as an example, this study aimed to develop a new method for CFR calculation while the pandemic was ongoing.</p></div><div><h3>Methods</h3><p>We developed a new method for CFR calculation based on the following formula: number of deaths divided by the number of cases T days before, where T is the average delay between case confirmation and disease outcome. An objective law was found using simulated data that states if the hypothesized T is equal to the true T, the calculated real-time CFR remains constant; whereas if the hypothesized T is greater (or smaller) than the true T, the real-time CFR will gradually decrease (or increase) as the days progress until it approaches the true CFR.</p></div><div><h3>Results</h3><p>Based on the discovered law, it was estimated that the true CFR of COVID-19 at the initial stage of the pandemic in China, excluding Hubei Province, was 0.8%; and in Hubei Province, it was 6.6%. The calculated CFRs predicted the death count with almost complete accuracy.</p></div><div><h3>Conclusions</h3><p>The method could be used for the accurate calculation of the true CFR during a pandemic, instead of waiting until the end of the pandemic, whether the pandemic is under control or not. It could provide those involved in outbreak control a clear view of the timeliness of case confirmations.</p></div>","PeriodicalId":100667,"journal":{"name":"Infectious Medicine","volume":"2 2","pages":"Pages 96-104"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50191552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Global Leprosy Assessment Index (GLAI): A new approach for measuring the severity of disease in Brazil 全球麻风病评估指数(GLAI):衡量巴西疾病严重程度的新方法
Pub Date : 2023-06-01 DOI: 10.1016/j.imj.2023.04.008
Lucas Silva , Thiago Rocha , Dalson Figueiredo Filho

Background

In Brazil, the Ministry of Health (MH) monitors leprosy using 15 indicators, with the aim of implementing and evaluating evidence-based public policies. However, an excessive number of variables can complicate the definition of objectives and verification of epidemiological goals.

Methods

In this paper, we develop the Global Leprosy Assessment Index (GLAI), a composite measure that integrates two key dimensions for the control the disease: epidemiological and operational. Using a confirmatory factor analysis model to examine 2020 state-level data, we have standardized GLAI to a range of 0 to 1.

Results

Higher values within this range indicate a greater severity of the disease. The mean value of the GLAI was 0.67, with a standard deviation of 0.22. Roraima has the highest value, followed by Paraíba with 0.88 while Tocantins records the lowest value of the indicator, followed by Mato Grosso with 0.14. The epidemiological and operational indicators have a positive but statistically insignificant correlation (r = 0.25; p-value = 0.20).

Conclusions

The development of evidence-based public policies depends on the availability of valid and reliable indicators. The GLAI presented in this paper is easily reproducible and can be used to monitor the disease with disaggregated information. Furthermore, the GLAI has the potential to serve as a more robust parameter for evaluating the impact of actions designed to eradicate leprosy in Brazil.

背景在巴西,卫生部使用15项指标监测麻风病,目的是实施和评估循证公共政策。然而,变量过多会使目标的定义和流行病学目标的验证复杂化。方法在本文中,我们制定了全球麻风病评估指数(GLAI),这是一项综合指标,综合了控制该疾病的两个关键维度:流行病学和操作性。使用验证性因素分析模型来检验2020年的州级数据,我们将GLAI标准化为0至1。结果该范围内的值越高,表明疾病的严重程度越高。GLAI的平均值为0.67,标准偏差为0.22。Roraima的值最高,其次是Paraíba,为0.88,而托坎廷斯的指标值最低,其次是马托格罗索,为0.14。流行病学指标与操作指标呈正相关,但统计学意义不显著(r=0.25;p值=0.20)。结论循证公共政策的制定取决于有效可靠指标的可用性。本文提出的GLAI易于复制,可用于监测疾病,并提供分类信息。此外,GLAI有可能成为评估巴西根除麻风病行动影响的一个更有力的参数。
{"title":"The Global Leprosy Assessment Index (GLAI): A new approach for measuring the severity of disease in Brazil","authors":"Lucas Silva ,&nbsp;Thiago Rocha ,&nbsp;Dalson Figueiredo Filho","doi":"10.1016/j.imj.2023.04.008","DOIUrl":"https://doi.org/10.1016/j.imj.2023.04.008","url":null,"abstract":"<div><h3>Background</h3><p>In Brazil, the Ministry of Health (MH) monitors leprosy using 15 indicators, with the aim of implementing and evaluating evidence-based public policies. However, an excessive number of variables can complicate the definition of objectives and verification of epidemiological goals.</p></div><div><h3>Methods</h3><p>In this paper, we develop the Global Leprosy Assessment Index (GLAI), a composite measure that integrates two key dimensions for the control the disease: epidemiological and operational. Using a confirmatory factor analysis model to examine 2020 state-level data, we have standardized GLAI to a range of 0 to 1.</p></div><div><h3>Results</h3><p>Higher values within this range indicate a greater severity of the disease. The mean value of the GLAI was 0.67, with a standard deviation of 0.22. Roraima has the highest value, followed by Paraíba with 0.88 while Tocantins records the lowest value of the indicator, followed by Mato Grosso with 0.14. The epidemiological and operational indicators have a positive but statistically insignificant correlation (<em>r</em> = 0.25; <em>p</em>-value = 0.20).</p></div><div><h3>Conclusions</h3><p>The development of evidence-based public policies depends on the availability of valid and reliable indicators. The GLAI presented in this paper is easily reproducible and can be used to monitor the disease with disaggregated information. Furthermore, the GLAI has the potential to serve as a more robust parameter for evaluating the impact of actions designed to eradicate leprosy in Brazil.</p></div>","PeriodicalId":100667,"journal":{"name":"Infectious Medicine","volume":"2 2","pages":"Pages 128-135"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50191553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical spectrum of ocular manifestations in COVID-19: a case series 新冠肺炎眼部临床表现谱:病例系列
Pub Date : 2023-06-01 DOI: 10.1016/j.imj.2023.04.001
Souheil Zayet , Ayoub Mihoubi , Marion Chatain , Nour Sreiri , Malek Bouzaien Trimech , Vincent Gendrin , Fatiha Benjelloun , Timothée Klopfenstein

In this current case series, all Coronavirus disease 2019 patients had predominant ophthalmological presentation. Only one patient sough care for concomitant respiratory symptoms. We reported herein 2 cases with cranial oculomotor nerve palsy, one patient with confirmed diagnosis of branch retinal vein occlusion, and the last one patient presenting for acute kareto-conjunctivitis with several recurrences, which was unsuccessfully treated with steroids and requiring cliclosporin. These case series highlights the importance of collecting a careful history of ocular presentation, including exposures to possible infected patients with SARS-CoV-2. This this will lead to an early diagnosis and treatment and to make appropriate infection control measures.

在目前的病例系列中,所有2019冠状病毒病患者都有主要的眼科表现。只有一名患者需要护理伴随的呼吸道症状。我们在此报告了2例颅骨动眼神经麻痹病例,一例确诊为视网膜分支静脉阻塞,最后一例患者出现急性卡累托结膜炎并多次复发,但类固醇治疗失败,需要使用cliclosporin。这些病例系列强调了收集仔细的眼部表现史的重要性,包括接触可能感染严重急性呼吸系统综合征冠状病毒2型的患者。这将导致早期诊断和治疗,并采取适当的感染控制措施。
{"title":"Clinical spectrum of ocular manifestations in COVID-19: a case series","authors":"Souheil Zayet ,&nbsp;Ayoub Mihoubi ,&nbsp;Marion Chatain ,&nbsp;Nour Sreiri ,&nbsp;Malek Bouzaien Trimech ,&nbsp;Vincent Gendrin ,&nbsp;Fatiha Benjelloun ,&nbsp;Timothée Klopfenstein","doi":"10.1016/j.imj.2023.04.001","DOIUrl":"https://doi.org/10.1016/j.imj.2023.04.001","url":null,"abstract":"<div><p>In this current case series, all Coronavirus disease 2019 patients had predominant ophthalmological presentation. Only one patient sough care for concomitant respiratory symptoms. We reported herein 2 cases with cranial oculomotor nerve palsy, one patient with confirmed diagnosis of branch retinal vein occlusion, and the last one patient presenting for acute kareto-conjunctivitis with several recurrences, which was unsuccessfully treated with steroids and requiring cliclosporin. These case series highlights the importance of collecting a careful history of ocular presentation, including exposures to possible infected patients with SARS-CoV-2. This this will lead to an early diagnosis and treatment and to make appropriate infection control measures.</p></div>","PeriodicalId":100667,"journal":{"name":"Infectious Medicine","volume":"2 2","pages":"Pages 148-152"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50191840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hesitant adopters: COVID-19 vaccine hesitancy among diverse vaccinated adults in the United States 犹豫不决的采用者:美国不同接种疫苗的成年人对新冠肺炎疫苗犹豫不决
Pub Date : 2023-06-01 DOI: 10.1016/j.imj.2023.03.001
Sharon Reece , Sheena CarlLee , Aaron J. Scott , Don E. Willis , Brett Rowland , Kristin Larsen , Ijanae Holman-Allgood , Pearl A. McElfish

Background

Despite the United States (US) having an abundant supply of COVID-19 vaccines, vaccination rates lag behind other high-income countries, suggesting that vaccine hesitancy and attitudes play a greater role in public health measures than pure supply and access. With the acknowledgment that vaccination attitudes and status may or may not be correlated, this study examined COVID-19 vaccine hesitancy among vaccinated US adults by asking: 1) What is the prevalence of COVID-19 vaccine hesitancy among the vaccinated? 2) Does COVID-19 vaccine hesitancy vary across sociodemographic characteristics? 3) Does COVID-19 vaccine hesitancy vary by healthcare access and influenza vaccination over the past 5 years?

Methods

Data were collected through an online survey of 2022 US adults with a final analytic sample of 1383 vaccinated respondents.

Results

Overall, 48.8% of vaccinated adults reported some level of hesitancy, while a slight majority reported they were “not at all hesitant”. Younger respondents, women, and Black and American Indian or Alaska Native participants had greater adjusted odds of being more hesitant towards receiving the COVID-19 vaccine. Respondents who had a primary care physician had greater adjusted odds than those who did not have a primary care physician of being more hesitant towards receiving the COVID-19 vaccine.

Conclusions

This is the first population-based national sample study examining COVID-19 vaccine hesitancy among vaccinated individuals from subgroups of distinctive backgrounds in order to inform targeted strategies for reducing vaccine hesitancy. Findings can assist in efforts to increase vaccination rates and also decrease vaccine hesitancy at the national level.

背景尽管美国拥有充足的新冠肺炎疫苗供应,但疫苗接种率落后于其他高收入国家,这表明疫苗犹豫和态度在公共卫生措施中的作用比单纯的供应和获取更大。鉴于疫苗接种态度和状态可能相关,也可能不相关,本研究通过以下问题调查了接种疫苗的美国成年人对新冠肺炎疫苗的犹豫:1)接种者中新冠肺炎疫苗犹豫的流行率是多少?2) 新冠肺炎疫苗犹豫是否因社会人口特征而异?3) 在过去5年中,新冠肺炎疫苗的犹豫是否因医疗保健和流感疫苗接种而有所不同?方法通过对2022名美国成年人的在线调查收集数据,最终分析样本为1383名接种疫苗的受访者。结果总体而言,48.8%的接种过疫苗的成年人表示有一定程度的犹豫,而极少数人表示“一点也不犹豫”。年轻的受访者、女性、黑人和美洲印第安人或阿拉斯加土著参与者对接种新冠肺炎疫苗更犹豫的调整后几率更大。与没有初级保健医生的受访者相比,有初级保健医师的受访者对接种新冠肺炎疫苗更犹豫的调整后几率更大。结论本研究是第一项基于人群的全国样本研究,旨在调查来自不同背景亚组的接种者对新冠肺炎疫苗的犹豫,为减少疫苗犹豫提供有针对性的策略。研究结果有助于提高疫苗接种率,并减少国家层面对疫苗的犹豫。
{"title":"Hesitant adopters: COVID-19 vaccine hesitancy among diverse vaccinated adults in the United States","authors":"Sharon Reece ,&nbsp;Sheena CarlLee ,&nbsp;Aaron J. Scott ,&nbsp;Don E. Willis ,&nbsp;Brett Rowland ,&nbsp;Kristin Larsen ,&nbsp;Ijanae Holman-Allgood ,&nbsp;Pearl A. McElfish","doi":"10.1016/j.imj.2023.03.001","DOIUrl":"https://doi.org/10.1016/j.imj.2023.03.001","url":null,"abstract":"<div><h3>Background</h3><p>Despite the United States (US) having an abundant supply of COVID-19 vaccines, vaccination rates lag behind other high-income countries, suggesting that vaccine hesitancy and attitudes play a greater role in public health measures than pure supply and access. With the acknowledgment that vaccination attitudes and status may or may not be correlated, this study examined COVID-19 vaccine hesitancy among vaccinated US adults by asking: 1) What is the prevalence of COVID-19 vaccine hesitancy among the vaccinated? 2) Does COVID-19 vaccine hesitancy vary across sociodemographic characteristics? 3) Does COVID-19 vaccine hesitancy vary by healthcare access and influenza vaccination over the past 5 years?</p></div><div><h3>Methods</h3><p>Data were collected through an online survey of 2022 US adults with a final analytic sample of 1383 vaccinated respondents.</p></div><div><h3>Results</h3><p>Overall, 48.8% of vaccinated adults reported some level of hesitancy, while a slight majority reported they were “not at all hesitant”. Younger respondents, women, and Black and American Indian or Alaska Native participants had greater adjusted odds of being more hesitant towards receiving the COVID-19 vaccine. Respondents who had a primary care physician had greater adjusted odds than those who did not have a primary care physician of being more hesitant towards receiving the COVID-19 vaccine.</p></div><div><h3>Conclusions</h3><p>This is the first population-based national sample study examining COVID-19 vaccine hesitancy among vaccinated individuals from subgroups of distinctive backgrounds in order to inform targeted strategies for reducing vaccine hesitancy. Findings can assist in efforts to increase vaccination rates and also decrease vaccine hesitancy at the national level.</p></div>","PeriodicalId":100667,"journal":{"name":"Infectious Medicine","volume":"2 2","pages":"Pages 89-95"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50191551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The liver-to-spleen ratio is a risk factor predicting oxygen demand in COVID-19 patients 肝脏与肾脏的比值是预测新冠肺炎患者氧气需求的一个风险因素
Pub Date : 2023-06-01 DOI: 10.1016/j.imj.2023.04.002
Hiromasa Nakayasu, Shogo Sakurai, Shuichi Sugiyama, Kotaro Shiratori, Kohei Okawa, Yoshihiro Kitahara, Shingo Takahashi, Toshihiro Masuda, Yutaro Kishimoto, Mika Saigusa, Akito Yamamoto, Taisuke Akamatsu, Satoru Morita, Kazuhiro Asada, Toshihiro Shirai

Background

We aimed to investigate risk factors predicting oxygen demand in COVID-19 patients.

Methods

Patients admitted to Shizuoka General Hospital with COVID-19 from August 2020 to August 2021 were included. First, we divided patients into groups with and without oxygen demand. Then, we compared patients' clinical characteristics and laboratory and radiological findings to determine factors predicting oxygen demand.

Results

One hundred seventy patients with COVID-19 (aged 58±15 years, 57 females) were enrolled. Common comorbidities were cardiovascular diseases (47.6%), diabetes mellitus (28.8%), and dyslipidemia (26.5%). Elder age, higher body mass index, cardiovascular diseases, diabetes mellitus, lower lymphocyte count, albumin, hepatic attenuation value, and the liver-to-spleen ratio (L/S), higher D-dimer, aspartate aminotransferase, lactate dehydrogenase, troponin-T, C-reactive protein, KL-6, chest and abdominal circumference, and visceral fat were found in patients with oxygen demand. According to the multivariate logistic regression analysis, L/S, lymphocyte count, D-dimer, and abdominal circumference under the diaphragm were independent risk factors predicting oxygen demand in COVID-19 patients.

Conclusions

On admission, L/S, lymphocyte count, D-dimer, and abdominal circumference were predictive factors for oxygen demand. These factors may help in the appropriate triage of COVID-19 patients in the decision to admit them to the hospital.

背景我们旨在调查预测新冠肺炎患者氧气需求的危险因素。方法纳入2020年8月至2021年8月入住静冈综合医院的新冠肺炎患者。首先,我们将患者分为有氧需求组和无氧需求组。然后,我们比较了患者的临床特征、实验室和放射学检查结果,以确定预测氧气需求的因素。结果纳入170例新冠肺炎患者(年龄58±15岁,女性57例)。常见的合并症是心血管疾病(47.6%)、糖尿病(28.8%)和血脂异常(26.5%)。年龄较大、体重指数较高、心血管疾病、糖尿病、淋巴细胞计数较低、白蛋白、肝脏衰减值和肝脾比(L/S)、D-二聚体、天冬氨酸氨基转移酶、乳酸脱氢酶、肌钙蛋白-T、C反应蛋白、KL-6,在有氧需求的患者中发现了胸部和腹部周长以及内脏脂肪。根据多变量逻辑回归分析,L/S、淋巴细胞计数、D-二聚体和横隔膜下腹围是预测新冠肺炎患者氧气需求的独立危险因素。结论入院时,L/S、淋巴细胞计数、D-二聚体和腹围是氧需求的预测因素。这些因素可能有助于对新冠肺炎患者进行适当的分诊,以决定是否让他们入院。
{"title":"The liver-to-spleen ratio is a risk factor predicting oxygen demand in COVID-19 patients","authors":"Hiromasa Nakayasu,&nbsp;Shogo Sakurai,&nbsp;Shuichi Sugiyama,&nbsp;Kotaro Shiratori,&nbsp;Kohei Okawa,&nbsp;Yoshihiro Kitahara,&nbsp;Shingo Takahashi,&nbsp;Toshihiro Masuda,&nbsp;Yutaro Kishimoto,&nbsp;Mika Saigusa,&nbsp;Akito Yamamoto,&nbsp;Taisuke Akamatsu,&nbsp;Satoru Morita,&nbsp;Kazuhiro Asada,&nbsp;Toshihiro Shirai","doi":"10.1016/j.imj.2023.04.002","DOIUrl":"https://doi.org/10.1016/j.imj.2023.04.002","url":null,"abstract":"<div><h3>Background</h3><p>We aimed to investigate risk factors predicting oxygen demand in COVID-19 patients.</p></div><div><h3>Methods</h3><p>Patients admitted to Shizuoka General Hospital with COVID-19 from August 2020 to August 2021 were included. First, we divided patients into groups with and without oxygen demand. Then, we compared patients' clinical characteristics and laboratory and radiological findings to determine factors predicting oxygen demand.</p></div><div><h3>Results</h3><p>One hundred seventy patients with COVID-19 (aged 58±15 years, 57 females) were enrolled. Common comorbidities were cardiovascular diseases (47.6%), diabetes mellitus (28.8%), and dyslipidemia (26.5%). Elder age, higher body mass index, cardiovascular diseases, diabetes mellitus, lower lymphocyte count, albumin, hepatic attenuation value, and the liver-to-spleen ratio (L/S), higher D-dimer, aspartate aminotransferase, lactate dehydrogenase, troponin-T, C-reactive protein, KL-6, chest and abdominal circumference, and visceral fat were found in patients with oxygen demand. According to the multivariate logistic regression analysis, L/S, lymphocyte count, D-dimer, and abdominal circumference under the diaphragm were independent risk factors predicting oxygen demand in COVID-19 patients.</p></div><div><h3>Conclusions</h3><p>On admission, L/S, lymphocyte count, D-dimer, and abdominal circumference were predictive factors for oxygen demand. These factors may help in the appropriate triage of COVID-19 patients in the decision to admit them to the hospital.</p></div>","PeriodicalId":100667,"journal":{"name":"Infectious Medicine","volume":"2 2","pages":"Pages 105-111"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50191837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospital bed capacity across in Tunisia hospital during the first 4 waves of the COVID-19 pandemic: A descriptive analysis 新冠肺炎大流行前4波期间突尼斯医院的病床容量:描述性分析
Pub Date : 2023-06-01 DOI: 10.1016/j.imj.2023.04.004
Slimane BenMiled , Chiraz Borgi , Mohamed Hsairi , Naoufel Somrani , Amira Kebir

Background

In March 2020, the WHO declared COVID-19 as a pandemic, and Tunisia implemented a containment and targeted screening strategy. The country's public health policy has since focused on managing hospital beds.

Methods

The study analyzed the bed occupancy rates in public hospitals in Tunisia during the pandemic. The evolution of daily cases and nonpharmaceutical interventions (NPI) actions undertaken by the Tunisian Government were also analyzed. The study used 3 indices to assess bed flexibility: Ramp duration until the peak, ramp growth until the peak, and ramp rate until the peak. The study also calculated the time shift at the start and peak of each wave to evaluate the government's response efficacy.

Results

The study found that the evolution of the epidemic in Tunisia had 2 phases. The first phase saw the pandemic being controlled due to strong NPI actions, while the second phase saw a relaxation of measures and an increase in wave intensity. ICU bed availability followed the demand for beds, but ICU bed occupancy remained high, with a maximum of 97%. The government's response in terms of bed distribution and reallocation was slow. The study found that the most deadly wave by ICU occupied bed was the third wave due to a historical variant, while the fifth wave due to the delta variant was the most deadly in terms of cumulative death.

Conclusions

The study concluded that decision-makers could use its findings to assess their response capabilities in the current pandemic and future ones. The study highlighted the importance of flexible and responsive healthcare systems in managing pandemics.

背景2020年3月,世界卫生组织宣布新冠肺炎为大流行病,突尼斯实施了遏制和有针对性的筛查战略。此后,该国的公共卫生政策一直侧重于管理医院床位。方法分析疫情期间突尼斯公立医院的床位占用率。还分析了突尼斯政府日常病例和非药物干预行动的演变。该研究使用了3个指标来评估床的灵活性:直到峰值的斜坡持续时间、直到峰值的坡道生长和直到峰值的坡度。该研究还计算了每波疫情开始和高峰期的时间偏移,以评估政府的应对效果。结果突尼斯疫情的演变分为两个阶段。在第一阶段,由于NPI的有力行动,疫情得到了控制,而在第二阶段,措施有所放松,波浪强度有所增加。ICU床位的可用性紧随床位需求,但ICU床位占用率仍然很高,最高可达97%。政府在床位分配和重新分配方面的反应很慢。研究发现,重症监护病房床位占用的最致命的一波是由历史变异引起的第三波,而由德尔塔变异造成的第五波是累计死亡人数最多的。结论该研究得出结论,决策者可以利用其研究结果来评估他们在当前和未来疫情中的应对能力。该研究强调了灵活和反应灵敏的医疗保健系统在管理流行病方面的重要性。
{"title":"Hospital bed capacity across in Tunisia hospital during the first 4 waves of the COVID-19 pandemic: A descriptive analysis","authors":"Slimane BenMiled ,&nbsp;Chiraz Borgi ,&nbsp;Mohamed Hsairi ,&nbsp;Naoufel Somrani ,&nbsp;Amira Kebir","doi":"10.1016/j.imj.2023.04.004","DOIUrl":"https://doi.org/10.1016/j.imj.2023.04.004","url":null,"abstract":"<div><h3>Background</h3><p>In March 2020, the WHO declared COVID-19 as a pandemic, and Tunisia implemented a containment and targeted screening strategy. The country's public health policy has since focused on managing hospital beds.</p></div><div><h3>Methods</h3><p>The study analyzed the bed occupancy rates in public hospitals in Tunisia during the pandemic. The evolution of daily cases and nonpharmaceutical interventions (NPI) actions undertaken by the Tunisian Government were also analyzed. The study used 3 indices to assess bed flexibility: Ramp duration until the peak, ramp growth until the peak, and ramp rate until the peak. The study also calculated the time shift at the start and peak of each wave to evaluate the government's response efficacy.</p></div><div><h3>Results</h3><p>The study found that the evolution of the epidemic in Tunisia had 2 phases. The first phase saw the pandemic being controlled due to strong NPI actions, while the second phase saw a relaxation of measures and an increase in wave intensity. ICU bed availability followed the demand for beds, but ICU bed occupancy remained high, with a maximum of 97%. The government's response in terms of bed distribution and reallocation was slow. The study found that the most deadly wave by ICU occupied bed was the third wave due to a historical variant, while the fifth wave due to the delta variant was the most deadly in terms of cumulative death.</p></div><div><h3>Conclusions</h3><p>The study concluded that decision-makers could use its findings to assess their response capabilities in the current pandemic and future ones. The study highlighted the importance of flexible and responsive healthcare systems in managing pandemics.</p></div>","PeriodicalId":100667,"journal":{"name":"Infectious Medicine","volume":"2 2","pages":"Pages 112-121"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50191838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Ventilator-associated pneumonia (VAP) and pleural empyema caused by multidrug-resistant Acinetobacter baumannii in HIV and COVID 19 infected patient: A case report 耐多药鲍曼不动杆菌在HIV和COVID-19感染患者中引起的呼吸机相关性肺炎(VAP)和胸膜积脓:一例报告
Pub Date : 2023-06-01 DOI: 10.1016/j.imj.2023.02.004
Rosa Anna Passerotto , Francesco Lamanna , Damiano Farinacci , Alex Dusina , Simona Di Giambenedetto , Arturo Ciccullo , Alberto Borghetti

We analyzed the case of a 49-year-old woman with HIV infection off-therapy with poor viro-immunological compensation, not vaccinated for SARS-COV-2, hospitalized for lobar pneumonia and severe COVID19-related respiratory failure in intensive care unit (ICU). The hospitalization was complicated by bacteraemic ventilator-associated pneumonia (VAP) caused by multidrug-resistant Acinetobacter baumannii (MDR-AB) isolated on pleural fluid culture, treated with colistin and cefiderocol for about 3 weeks. The molecular research of MDR-AB on transtracheal aspirate was negative following this therapy.

The aim is to show the safety, efficacy and tolerability of colistin-based combination therapy with cefiderocol for Acinetobacter baumannii infection in HIV-infected patient.

我们分析了一名49岁的HIV感染女性的病例,该女性因病毒免疫补偿差而退出治疗,未接种严重急性呼吸系统综合征冠状病毒2型疫苗,因大叶性肺炎和严重新冠肺炎相关呼吸衰竭在重症监护室(ICU)住院。住院患者因胸膜液培养分离的耐多药鲍曼不动杆菌(MDR-AB)引起的呼吸机相关性细菌性肺炎(VAP)而复杂,用粘菌素和头孢iderocol治疗约3周。MDR-AB在该疗法后经气管抽吸物上的分子研究为阴性。目的是证明以粘菌素为基础的联合头孢iderocol治疗HIV感染患者鲍曼不动杆菌感染的安全性、有效性和耐受性。
{"title":"Ventilator-associated pneumonia (VAP) and pleural empyema caused by multidrug-resistant Acinetobacter baumannii in HIV and COVID 19 infected patient: A case report","authors":"Rosa Anna Passerotto ,&nbsp;Francesco Lamanna ,&nbsp;Damiano Farinacci ,&nbsp;Alex Dusina ,&nbsp;Simona Di Giambenedetto ,&nbsp;Arturo Ciccullo ,&nbsp;Alberto Borghetti","doi":"10.1016/j.imj.2023.02.004","DOIUrl":"https://doi.org/10.1016/j.imj.2023.02.004","url":null,"abstract":"<div><p>We analyzed the case of a 49-year-old woman with HIV infection off-therapy with poor viro-immunological compensation, not vaccinated for SARS-COV-2, hospitalized for lobar pneumonia and severe COVID19-related respiratory failure in intensive care unit (ICU). The hospitalization was complicated by bacteraemic ventilator-associated pneumonia (VAP) caused by multidrug-resistant <em>Acinetobacter baumannii</em> (MDR-AB) isolated on pleural fluid culture, treated with colistin and cefiderocol for about 3 weeks. The molecular research of MDR-AB on transtracheal aspirate was negative following this therapy.</p><p>The aim is to show the safety, efficacy and tolerability of colistin-based combination therapy with cefiderocol for <em>Acinetobacter baumannii</em> infection in HIV-infected patient.</p></div>","PeriodicalId":100667,"journal":{"name":"Infectious Medicine","volume":"2 2","pages":"Pages 143-147"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50191548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gastrointestinal tuberculosis: An autopsy-based study 胃肠道结核:一项基于尸检的研究
Pub Date : 2023-06-01 DOI: 10.1016/j.imj.2023.04.007
Julio Cesar Mantilla , Juan José Chaves , Ferney Africano-Lopez , Néstor Blanco-Barrera , Marta Juliana Mantilla

Background

Tuberculosis is a disease of great relevance since it is one of the leading causes of morbidity and mortality worldwide. Gastrointestinal tuberculosis is an unusual presentation. It is defined as the involvement of any segment of the digestive tract, associated viscera, and peritoneum. The study's main objective is to collect information from autopsies of patients diagnosed with gastrointestinal tuberculosis in a Pathology reference center in Colombia.

Methods

This is a retrospective and descriptive study of autopsy reports. A total of 4,500 autopsies were performed between January 2004 and December 2020. The inclusion criteria were authorization of a family member following local law regulations and a final autopsy diagnosis of gastrointestinal tuberculosis using microscopic visualization.

Results

Forty-eight patients with gastrointestinal tuberculosis autopsies were included in our study. Most of the patients were male (n = 35, 72.9%) with a median age of 40.5 years old. Human immunodeficiency virus infection history was reported in 28 cases (58.33%). The most affected gastrointestinal tract site was the terminal ileum. Ulcers and thickened epithelium were common autopsies macroscopic findings. Tuberculosis multiorgan compromise was a relevant finding in patients with gastrointestinal tuberculosis.

Conclusions

Gastrointestinal tuberculosis is a disease of great importance, being its diagnosis a clinical challenge. Underdiagnosis can be reported in a high percentage of cases, so autopsy diagnosis can help reveal more accurate data about this condition.

背景肺结核是一种相关性很强的疾病,因为它是全球发病率和死亡率的主要原因之一。胃肠道结核是一种不寻常的表现。它被定义为涉及消化道的任何部分、相关内脏和腹膜。这项研究的主要目的是从哥伦比亚病理学参考中心诊断为胃肠道结核病患者的尸检中收集信息。方法对尸检报告进行回顾性和描述性研究。2004年1月至2020年12月期间,共进行了4500次尸检。纳入标准是根据当地法律法规授权一名家庭成员,并使用显微镜可视化对胃肠道结核病进行最终尸检诊断。结果48例消化道结核患者的尸体解剖纳入本研究。大多数患者为男性(n=35,72.9%),中位年龄为40.5岁。28例(58.33%)报告了人类免疫缺陷病毒感染史。受影响最严重的胃肠道部位是末端回肠。溃疡和增厚的上皮是常见的尸检宏观发现。肺结核多器官损害是胃肠道结核患者的相关发现。结论胃肠道结核是一种重要的疾病,对其诊断是一项临床挑战。诊断不足的病例比例很高,因此尸检诊断有助于揭示有关这种情况的更准确数据。
{"title":"Gastrointestinal tuberculosis: An autopsy-based study","authors":"Julio Cesar Mantilla ,&nbsp;Juan José Chaves ,&nbsp;Ferney Africano-Lopez ,&nbsp;Néstor Blanco-Barrera ,&nbsp;Marta Juliana Mantilla","doi":"10.1016/j.imj.2023.04.007","DOIUrl":"https://doi.org/10.1016/j.imj.2023.04.007","url":null,"abstract":"<div><h3>Background</h3><p>Tuberculosis is a disease of great relevance since it is one of the leading causes of morbidity and mortality worldwide. Gastrointestinal tuberculosis is an unusual presentation. It is defined as the involvement of any segment of the digestive tract, associated viscera, and peritoneum. The study's main objective is to collect information from autopsies of patients diagnosed with gastrointestinal tuberculosis in a Pathology reference center in Colombia.</p></div><div><h3>Methods</h3><p>This is a retrospective and descriptive study of autopsy reports. A total of 4,500 autopsies were performed between January 2004 and December 2020. The inclusion criteria were authorization of a family member following local law regulations and a final autopsy diagnosis of gastrointestinal tuberculosis using microscopic visualization.</p></div><div><h3>Results</h3><p>Forty-eight patients with gastrointestinal tuberculosis autopsies were included in our study. Most of the patients were male (<em>n</em> = 35, 72.9%) with a median age of 40.5 years old. Human immunodeficiency virus infection history was reported in 28 cases (58.33%). The most affected gastrointestinal tract site was the terminal ileum. Ulcers and thickened epithelium were common autopsies macroscopic findings. Tuberculosis multiorgan compromise was a relevant finding in patients with gastrointestinal tuberculosis.</p></div><div><h3>Conclusions</h3><p>Gastrointestinal tuberculosis is a disease of great importance, being its diagnosis a clinical challenge. Underdiagnosis can be reported in a high percentage of cases, so autopsy diagnosis can help reveal more accurate data about this condition.</p></div>","PeriodicalId":100667,"journal":{"name":"Infectious Medicine","volume":"2 2","pages":"Pages 122-127"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50191839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infectious Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1